Literature DB >> 9251206

Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde.

M Chambon1, C Jallat-Archimbaud, J L Bailly, J M Gourgand, F Charbonne, C Henquell, F Fuchs, H Peigue-Lafeuille.   

Abstract

Significant intratypic differences in the glutaraldehyde (GTA) sensitivity of echovirus isolates have been shown. While exploring ways to optimize the study of GTA sensitivity of enteroviruses, we also observed intratypic differences in poliovirus type 1 isolates collected in France. A suspension procedure was used for assessing the virucidal effect of GTA at low concentrations (< or = 0.10%) against purified viruses. Two recent isolates of poliovirus type 1 tested were first fully characterized by the PCR restriction fragment length polymorphism (RFLP) test. The RFLP pattern of clinical isolate 5617 was similar to that of poliovirus type 1 LS-c, 2ab (Sabin strain), confirming the vaccine origin of strain 5617. The RFLP pattern of strain 5915 recovered from sewage was different from that of the Mahoney strain, suggesting a genetic variation in this wild isolate. We then analyzed under the same controlled conditions the GTA sensitivities of both isolates and their respective prototype strains. The wild Mahoney and 5915 strains exhibited significantly lower sensitivities to GTA than did the vaccine Sabin and 5617 strains. The inactivation rates of clinical isolates 5617 and 5915 were very similar to those of their corresponding reference Sabin and Mahoney strains. Both the conformational structure of the capsid of each strain and the amino acid constitution of structural polypeptides could be involved in the variations observed. The relevance of our comparative sensitivity studies to standardization of virucidal tests is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9251206      PMCID: PMC168617          DOI: 10.1128/aem.63.8.3199-3204.1997

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  24 in total

1.  Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee.

Authors:  P D Minor; A John; M Ferguson; J P Icenogle
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

2.  Chronic group A coxsackievirus infection in agammaglobulinemia: demonstration of genomic variation of serotypically identical isolates persistently excreted by the same patient.

Authors:  K M O'Neil; M A Pallansch; J A Winkelstein; T M Lock; J F Modlin
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

3.  Virion conformational forms and the complex inactivation kinetics of echovirus by chlorine in water.

Authors:  D C Young; D G Sharp
Journal:  Appl Environ Microbiol       Date:  1985-02       Impact factor: 4.792

4.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

5.  Glutaraldehyde: nature of the reagent.

Authors:  A H Korn; S H Feairheller; E M Filachione
Journal:  J Mol Biol       Date:  1972-04-14       Impact factor: 5.469

6.  Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

Authors:  H Toyoda; M Kohara; Y Kataoka; T Suganuma; T Omata; N Imura; A Nomoto
Journal:  J Mol Biol       Date:  1984-04-25       Impact factor: 5.469

7.  Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping.

Authors:  P D Minor; G C Schild; M Ferguson; A Mackay; D I Magrath; A John; J P Yates; M Spitz
Journal:  J Gen Virol       Date:  1982-08       Impact factor: 3.891

8.  High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies.

Authors:  B S Prabhakar; M V Haspel; P R McClintock; A L Notkins
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

9.  Natural variation of poliovirus neutralization epitopes.

Authors:  R Crainic; P Couillin; B Blondel; N Cabau; A Boué; F Horodniceanu
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.

Authors:  O M Kew; B K Nottay; M H Hatch; J H Nakano; J F Obijeski
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

View more
  3 in total

1.  New method for evaluation of virucidal activity of antiseptics and disinfectants.

Authors:  G T Papageorgiou; L Mocé-Llivina; J Jofre
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

2.  Virucidal efficacy of glutaraldehyde against enteroviruses is related to the location of lysine residues in exposed structures of the VP1 capsid protein.

Authors:  Martine Chambon; Christine Archimbaud; Jean-Luc Bailly; Jeanne-Marie Gourgand; Françoise Charbonné; Hélène Peigue-Lafeuille
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

Review 3.  Viricidal treatments for prevention of coronavirus infection.

Authors:  Manoj Khokhar; Dipayan Roy; Purvi Purohit; Manu Goyal; Puneet Setia
Journal:  Pathog Glob Health       Date:  2020-09-02       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.